* Newstin.com is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.com and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.com is for sale! *

Sanofi

Australian flu headed for Britain

upi.com
Sep 30, 2008 9 related
        

LONDON, Sept. 30 (UPI) -- British health officials are preparing for the arrival of an Australian flu virus, Brisbane H3N2, which has claimed hundreds of lives. The Daily Mail said more than 800 people died of pneumonia...

add comment
                   

Sanofi drug rival delayed, but maybe not for long

finanznachrichten.de
Sep 29, 2008 5 related
        

LONDON, Sept 29 (Reuters) - Sanofi-Aventis and Bristol-Myers Squibb have escaped the immediate threat of competition from prasugrel, a new rival to their blockbuster drug Plavix, but the respite may not last long. The...

add comment
                   
mailonsunday.co.uk: Flu fact File Graphic.jpg mailonsunday.co.uk

Coming to Britain - the Australian flu virus that has already killed hundreds

mailonsunday.co.uk
Sep 28, 2008 2 related
        

A flu virus more deadly than any seen in two decades is threatening Britain. The strain originates in Australia where it has claimed hundreds of lives, including those of children. Called Brisbane H3N2, it is so virulent...

add comment
                   

ESU unveils Hoeffner Center

poconorecord.com
Sep 27, 2008
        

Science building designed to foster interaction among various disciplines People gather for the ribbon-cutting ceremony for the Warren E. and Sandra Hoeffner Science and Technology Center on Friday.David Kidwell/Pocono...

add comment
                   

ImClone in payment dispute over Erbitux

newyorkbusiness.com
Sep 26, 2008 1 related
        

ImClone Systems Inc. said Friday its European Erbitux partner Merck KGaA disputes a portion of royalty payments, citing a breach of contract. In a Securities and Exchange Commission filing Friday, Manhattan-based ImClone...

add comment

Biotech Stocks: Biogen, Pfizer lead drug stocks higher

marketwatch.com
Sep 25, 2008 4 related
        

By Val Brickates Kennedy, MarketWatch BOSTON (MarketWatch) -- Drug stocks rallied in midday action Thursday with several of the large-cap players gaining at least 2%. The Amex Pharmaceutical Index jumped 2.1% to 298.82,...

add comment
                   

Sanofi Gets the Golden Ring (at Motley Fool)

yahoo.com
Sep 24, 2008 7 related
        

It looks like Sanofi-Aventis (NYSE: SNY) isn’t shying away from its recently announced new goals for itself. Only a little less than two weeks after proclaiming it would make expanding into the generic-drug business one...

add comment
                   

Buffett’s Goldman Deal Has Big Benefits, but What Else is Berkshire Up To?

moneymorning.com
Sep 25, 2008 405 related
        

By Jason Simpkins Associate Editor Investing icon Warren Buffett took his own advice Tuesday - getting "greedy when others are fearful" - when he ignored the banking-sector bonfire and slapped down a cool $5 billion for a...

add comment
                   

FDA Approves Nasacort AQ(R) Nasal Spray For Children Aged 2 - 5 Years Old

medicalnewstoday.com
Sep 24, 2008 4 related
        

Sanofi-aventis announced the U.S. Food and Drug Administration (FDA) has approved Nasacort AQ Nasal Spray (triamcinolone acetonide) for children aged 2 - 5 years old for the treatment of nasal symptoms associated with...

add comment

Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective...

medicalnewstoday.com
Jul 23, 2008 5 related
        

Results from the "Adjust to Target in Type 2 Diabetes: Comparison of a Simple Algorithm to Carbohydrate Counting for Adjustment of Mealtime Insulin Glulisine" study, were published in the American Diabetes Association's (ADA)...

add comment